Literature DB >> 3708691

Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains.

D Young, G Waitches, C Birchmeier, O Fasano, M Wigler.   

Abstract

We have cloned and sequenced a new human oncogene and have named it mas. This oncogene was detected by its tumorigenicity in nude mice using the cotransfection and tumorigenicity assay previously described. The mas oncogene has a weak focus-inducing activity in transfected NIH 3T3 cells. A DNA rearrangement in the 5' noncoding sequence, which occurred during transfection, is probably responsible for activation of the mas gene. The cDNA sequence of the mas oncogene reveals a long open reading frame that codes for a 325 amino acid protein. This protein is very hydrophobic and has seven potential transmembrane domains. In this respect, the structure of the mas protein is novel among cellular oncogene products and may reflect a new functional class of oncogenes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3708691     DOI: 10.1016/0092-8674(86)90785-3

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  120 in total

Review 1.  In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors.

Authors:  T M Savarese; C M Fraser
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

2.  Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential.

Authors:  S Katzav; J L Cleveland; H E Heslop; D Pulido
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

3.  RTA, a candidate G protein-coupled receptor: cloning, sequencing, and tissue distribution.

Authors:  P C Ross; R A Figler; M H Corjay; C M Barber; N Adam; D R Harcus; K R Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

Review 4.  G protein-coupled receptors: novel targets for drug discovery in cancer.

Authors:  Rosamaria Lappano; Marcello Maggiolini
Journal:  Nat Rev Drug Discov       Date:  2011-01       Impact factor: 84.694

Review 5.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

6.  Characterization of the Mas-related gene family: structural and functional conservation of human and rhesus MrgX receptors.

Authors:  Ethan S Burstein; Thomas R Ott; Michele Feddock; Jian-Nong Ma; Steve Fuhs; Steven Wong; Hans H Schiffer; Mark R Brann; Norman R Nash
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

7.  Structure and transforming potential of the human cot oncogene encoding a putative protein kinase.

Authors:  J Miyoshi; T Higashi; H Mukai; T Ohuchi; T Kakunaga
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

8.  An in vivo screening system to identify tumorigenic genes.

Authors:  T Ihara; Y Hosokawa; K Kumazawa; K Ishikawa; J Fujimoto; M Yamamoto; T Muramkami; N Goshima; E Ito; S Watanabe; K Semba
Journal:  Oncogene       Date:  2016-10-03       Impact factor: 9.867

9.  Anti-inflammatory effects of angiotensin-(1-7) in ischemic stroke.

Authors:  Robert W Regenhardt; Fiona Desland; Adam P Mecca; David J Pioquinto; Aqeela Afzal; J Mocco; Colin Sumners
Journal:  Neuropharmacology       Date:  2013-04-11       Impact factor: 5.250

Review 10.  Involvement of metabotropic glutamate receptor 1, a G protein coupled receptor, in melanoma development.

Authors:  Yarí E Marín; Suzie Chen
Journal:  J Mol Med (Berl)       Date:  2004-08-21       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.